The Ministry of Health and Population announced that the Al-Mabara Heart Academy, affiliated with the Therapeutic Institute, has been certified by the European Association of Cardiovascular Imaging (EACVI) as a regional center for cardiovascular imaging training.
A Ministry representative, Hossam Abdel Ghaffar, noted that this accreditation is a significant achievement. The Al-Mabara Heart Academy is now the first certified center in Egypt and Africa, and the fourth in the Middle East, joining a global network of only 100 accredited centers worldwide.
He added that this success demonstrates the Therapeutic Institute's efforts to advance medical and educational excellence by implementing advanced cardiovascular imaging technologies and applying the highest international European standards.
The center will contribute to the development of Egyptian and African medical specialists, strengthening the healthcare system's capacity for early and accurate diagnosis of cardiovascular diseases.
Mohamed Shakir, Chairman of the Therapeutic Institute, stated that the accreditation was achieved through strategic partnerships with sustainable development partners, among whom the Commercial International Bank (CIB) played a key role by supporting the academy's infrastructure and technical capabilities.
Shakir emphasized that this accreditation reflects a national achievement, demonstrating Egypt's commitment to raising healthcare standards in line with global standards, as well as the continuous building of capacity for doctors and researchers and strengthening Egypt's position in world medicine, especially cardiology.
The Al-Mabara Heart Academy stands as an example of Egyptian medical excellence, combining advanced clinical experience, internationally accredited curricula, and modern technology to provide outstanding diagnostic services and training at both regional and global levels.
Climate activist Sonam Wangchuk continues to reject medical recommendations regarding the intake of intravenous fluids and glucose. Meanwhile, his sugar levels remain low, and his serum potassium level has dropped to 3.2 mEq/L.
According to the latest bulletin released by VMMC & Safdarjung Hospital on Tuesday morning, laboratory tests revealed persistent pancytopenia—a condition characterized by a decrease in blood cell count. Despite this, Wangchuk's vital signs remain stable.
Doctors note that Wangchuk is currently receiving therapy with oral rehydration salts (ORS) and supplementary internal potassium intake. Nevertheless, he stubbornly refuses intravenous fluids and glucose, despite repeated warnings from medical staff.
Due to ongoing mild or moderate dehydration, persistent deviations in laboratory parameters, and physiological stress associated with prolonged fasting, constant clinical monitoring and medical observation remain critically important for his recovery and the timely detection of any possible complications.
Wangchuk is under close observation by a multidisciplinary team of specialists from VMMC & Safdarjung Hospital and AIIMS, New Delhi. The hospital confirmed that all necessary medical care is being provided, and his clinical condition is constantly being assessed. Further treatment will be determined by his progress and the results of sequential laboratory tests.
The Palliative Care Association expressed concern by pointing out that the Government has not appointed the commission responsible for supervising the sector for over a year.
The organization emphasized that it has been waiting for more than twelve months for the official designation of the commission that must oversee palliative care practices and operations in the country.
In the island province of Hainan in southern China, futuristic developments are moving from laboratories to reality in the fields of advanced technology and affordable healthcare. This has been made possible by the preferential policy operating in the Hainan Free Trade Port.
At Hainan University, a team led by Professor Huang Zhong created a biomimetic fish capable of covering a distance of 50 meters in under 20 seconds, surpassing the previous world record of 22.16 seconds. Robots inspired by living organisms such as fish and snakes have the potential to operate in extreme conditions, including deep-sea exploration and radiation-exposed industrial zones.
Huang suggests developing brain-computer interfaces that can enable a symbiosis between humans and machines, potentially assisting stroke patients or allowing remote surgery in deep water. He also noted that the Free Trade Port provides an ideal platform for testing open data and marine robotic systems.
Meanwhile, a biotechnology company based in the capital, Haikou, has localized cartilage regeneration therapy, which was previously considered irreversible. This has made treatment more accessible to ordinary patients by reducing costs.
The team converted beef cartilage into a decellularized matrix and demonstrated that this material effectively supports cartilage cell growth. According to Zeng Shen, founder of Susheng Biotech, restoration was confirmed in over 60 patients using this material. He emphasized that the cost of the material, which is about $1000 (slightly more than 6700 yuan) abroad, is now available in Hainan for approximately $68 (460 yuan) per gram.
This significant price reduction is partly due to the abolition of import duties and a corporate tax rate of 15%, which is one of the lowest in the world. Zeng reported that international patients from the Middle East and Southeast Asia are already coming for treatment.
A local pharmaceutical company in Hainan brought a chemotherapy protection drug to market just 17 months after its approval in the US, significantly faster than the standard timeframe of three to five years. Localizing production allowed the drug's price to drop from $1400 (close to 9500 yuan) in the US to $68 (460 yuan) in China.
Yu Qingzhu, Chairman of Simcere, stated that in 2025, the company signed an intellectual property export agreement worth $5 billion with an American firm, effectively using Hainan as its gateway to global markets.
From deep-sea biomimetic modeling to cellular regeneration and cross-border pharmaceutical innovations, Hainan demonstrates that institutional reforms and scientific research can go hand in hand, turning breakthroughs into accessible benefits for patients worldwide.
